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DObjective: Outcomes of patients with single ventricle physiology undergoing cavopulmonary palliations
depend on pulmonary vascular resistance (PVR) and have been suggested to be adversely affected by living
at elevated altitude. We compared the pulmonary hemodynamic data in correlation with postoperative outcomes
at the 3 centers of Denver, Edmonton, and Toronto at altitudes of 1604, 668, and 103 meters, respectively.
Methods: Hemodynamic data at pre-bidirectional cavopulmonary anastomosis (BCPA) and pre-Fontan cathe-
terization between 1995 and 2007 were collected. Death from cardiac failure or heart transplantation in the same
period was used to define palliation failure.
Results: There was no significant correlation between altitude (ranged from 1 to 2572 meters) and PVR, pulmo-
nary artery pressure (PAP) or transpulmonary gradient (TPG) at pre-BCPA and pre-Fontan catheterization. BCPA
failure occurred in 11 (9.2%) patients inDenver, 3 (2.9%) inEdmonton, and34 (11.9%) inToronto. Fontan failure
occurred in 3 (6.1%) patients in Denver, 5 (7.2%) in Edmonton, and 11 (7.0%) in Toronto. There was no signif-
icant difference inBCPAandFontan failure among the 3 centers. BCPA failure positively correlatedwith PVRand
the presence of a right ventricle as the systemic ventricle. Fontan failure positively correlated with PAP and TPG.
Conclusions: Moderate altitude is not associated with an increased PVR or adverse outcomes in patients with
a functional single ventricle undergoing BCPA and the Fontan operation. The risk factors for palliation failure
are higher PVR, PAP, and TPG and a systemic right ventricle, but not altitude. Our study reemphasizes the
importance of cardiac catheterization assessments of pulmonary hemodynamics before BCPA and Fontan
operations. (J Thorac Cardiovasc Surg 2013;146:1165-71)The surgicalmanagement of a functional single ventricle has
evolved into a staged pathway, which includes bidirectional
cavopulmonary anastomosis (BCPA) and Fontan opera-
tions, to route the systemic venous return into the pulmonary
circulation. Therefore, low pulmonary arterial pressure
(PAP) and vascular resistance (PVR) are major criteria for
optimal outcomes after the cavopulmonary palliations.1,2
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The Journal of Thoracic and Carmay cause pulmonary vasoconstriction resulting in an ele-
vated PAP and PVR.3-5 Intuitively, altitude has been
considered to negatively affect pulmonary hemodynamics
and thus postoperative outcomes for patients with
functional single ventricle.1,6,7 However, reports from the
single-center studies at moderate altitude in Denver, Colo-
rado, and Salt Lake City, Utah, have shown favorable out-
comes that are comparable with centers at sea level.7,8 In
Denver’s study, risk factors for palliation failure included
higher PAP and PVR.8 Amulticentered study from different
attitudes with a direct comparison of hemodynamics and
postoperative outcomes in age-matched populations is nec-
essary to demonstrate an impact of altitude. Therefore, we
aimed, first, to compare the hemodynamic variables at rou-
tine pre-BCPA and pre-Fontan cardiac catheterization and
correlate them to the postoperative outcomes among the
3 centers in Denver, Colorado (altitude, 1604 meters), Ed-
monton, Alberta (668 meters), and Toronto, Ontario (103
meters), which represent an altitude range of most world-
wide centers performing staged palliations for patients
with functional single ventricle. The second aim was to fur-
ther examine the effect of pulmonary hemodynamics on the
postoperative outcomes in these patients.diovascular Surgery c Volume 146, Number 5 1165
Abbreviations and Acronyms
BCPA ¼ bidirectional cavopulmonary anastomosis
PAP ¼ pulmonary arterial pressure
PVR ¼ pulmonary vascular resistance
TPG ¼ transpulmonary pressure gradient
VEDP ¼ ventricular end-diastolic pressure
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DMETHODS
Patients
A retrospective review of patient records was performed in accordance
with research protocols approved by the institutionalResearchEthicsBoards
at Children’s Hospital in Denver, Colorado, Stollery Children’s Hospital in
Edmonton, Alberta, Canada, and the Hospital for Sick Children in Toronto,
Ontario, Canada. Data were collected in patients with functional single ven-
tricle who underwent a BCPA between January 1995 and March 2007. Pa-
tients with genetic syndromes were excluded. A total of 506 patients born
between January 1, 1995, andDecember 31, 2006,were enrolled in the study,
including 119 patients in Denver, 102 in Edmonton, and 285 in Toronto.
Diagnosis and Surgical Techniques
Table 1 summarizes the specific cardiac diagnoses of patients from the 3
centers, the morphologic characteristics of the functional systemic ventricle,
and surgery performed before BCPA. Surgical techniques of BCPA and Fon-
tan operations did not differ among the 3 centers, representing the standard
worldwide practice. At BCPA, the superior vena cava was transected at the
level of the right pulmonary artery and anastomosed to the superior border
of the right pulmonary artery. Extracardiac Fontan operation was performed
in the majority of patients using an 18- or 20-mm expanded polytetrafluoro-
ethylenegraft anastomosed to theundersurface of themain pulmonary artery,
offset to the left of the BCPA. For patients who underwent a fenestration (24
in Denver, 51 in Edmonton, and 110 in Toronto), a 4- to 5-mm fenestration
was created between the Fontan conduit and the common atrial free wall.
Altitude and Hemodynamic Assessments
The altitude and diagnoses were recorded at the patient’s place of resi-
dence at time of BCPA and displayed in Figure 1.
Hemodynamic data were collected at routine pre-BCPA and pre-Fontan
cardiac catheterizations, including systolic and mean PAP, mean left atrial
or pulmonary capillary wedge pressure, transpulmonary pressure gradient
(TPG), ventricular end-diastolic pressure (VEDP), arterial oxygen satura-
tion, and pulmonary arterial and venous oxygen saturations. At pre-
BCPA, pulmonary arterial oxygen saturation is equal to the arterial oxygen
saturation in patients after the Norwood procedure.
Oxygen consumption was uniformly recalculated for all patients using
the Lindahl equation,9 as follows:
For children weighing less than 10 kg, oxygen consumption (mL/
min) ¼ (6.8 3 weight) þ 8.0.
For those weighing more than 10 kg, oxygen consumption (mL/
min) ¼ (4.0 3 weight) þ 35.8.
Oxygen consumption was indexed to body surface area. Pulmonary
blood flow was calculated using the direct Fick principle to allow the der-
ivation of PVR.
Follow-up and Outcomes
Follow-up protocol was similar among the 3 centers, by which patients
were examined at about 6-month intervals and more frequently if the
child’s status changed. Follow-up information was obtained from the last
patient assessment by the pediatric cardiologist or referring pediatrician
until March 2007. It was completed in 112 (94%) patients at a median1166 The Journal of Thoracic and Cardiovascular Surperiod of 3.0 years (range, 0.02-12.5 years) in Denver; in 93 (91.2%) pa-
tients at a median period of 6.1 years (range, 0.79-12.3 years) in Edmonton,
and in 251 (88.1%) patients at a median period of 3.2 years (range, 0-11.4
years) in Toronto. In-hospital death was defined as death occurring during
the same hospital admission after the BPCA or Fontan operation. Palliation
failure after BCPA and Fontan operation was defined as death from cardiac
failure or need for heart transplantation.
Data Analysis
Data were described as median with range or mean with standard
deviation. Survival was calculated as the number of patients undergoing
BCPA minus the number of deaths divided by the number of patients
undergoing BCPA. Palliation failure rate was calculated as the number
of deaths and needs for heart transplantations divided by the number of
patients undergoing BCPA or Fontan operation for 1, 5, and 10 years after
each palliation. The c2 test was used to examine the difference in the dis-
tribution of cardiac diagnoses and surgical procedures before BCPA in
the 3 centers. Analysis of variance was used to compare the demographic
data (age, weight, and body surface area) in patients among the 3 centers.
Simple linear regression was used to examine the correlations between
continuous data including altitude, center (Denver as 0, Edmonton as 1,
and Toronto as 2, according to the ascending levels of altitude), and
hemodynamic variables. Logistic regression was used to determine the
relationship between the categorical data of palliation failures, altitude,
and hemodynamic variables. Paired t test was used to compare the
variables between BCPA and Fontan operation. All data analysis was
performed using SAS statistical software version 9.3 (SAS Institute, Inc,
Cary, NC).RESULTS
Patients
The altitude ranged from 1 to 2572 meters in the patients
from the 3 centers. There was no significant difference in
age, weight, or body surface area at pre-BCPA or pre-
Fontan catheterization among the centers (Table 2). There
were 104, 80, and 259 patients undergoing pre-BCPA cath-
eterization; 119, 102, and 285 patients undergoing BCPA
surgery; and 1, 0, and 14 in-hospital deaths in Denver,
Edmonton, and Toronto, respectively. Subsequently, there
were 49, 59, and 170 patients undergoing pre-Fontan cath-
eterization; 49, 69, and 155 patients undergoing the Fontan
operation; and 0, 1, and 3 in-hospital deaths for early post-
operative mortality in Denver, Edmonton, and Toronto,
respectively. In Denver, there was 1 patient who did not
have pre-BCPA catheterization among the 11 patients
with BCPA failure. In Edmonton, there was 1 patient who
did not have pre-BCPA catheterization among the 3 patients
with BCPA failure, and 1 patient with no pre-Fontan cathe-
terization among the 5 patients with Fontan failure. In
Toronto, there were 2 patients who did not have pre-
BCPA catheterization among the 31 patients with BCPA
failure. On the other hand, among the 17 patients who had
pre-Fontan catheterization but did not have the Fontan
operation, 4 patients have had PVR above 3 Wood
units3m2 (3.4, 4.5, 7.3, and 8.7 Wood units3m2, respec-
tively), 2 patients (PVR, 7.3 and 8.7 Wood units 3 m2, re-
spectively) lost to follow-up, and the other 2 patients did not
have BCPA failure. In Edmonton, 6 patients had pre-Fontangery c November 2013
TABLE 1. The distribution of cardiac diagnoses and surgical
procedures before BCPA in the 3 centers
Denver,
n (%)
Edmonton,
n (%)
Toronto,
n (%)
P
value
No. of patients 119 102 285
Diagnosis
HLHS 26 (21.8) 42 (41.1) 101 (35.4) .005
TA 35 (29.4) 19 (18.6) 45 (15.8) .01
PAþVSD 9 (7.6) 9 (8.8) 15 (5.3) .42
PAþIVS, hypoplastic RV 11 (9.2) 6 (5.9) 25 (8.8) .59
DILV, L-TGA, PS 11 (9.2) 16 (15.7) 23 (8.1) .02
DORV 12 (10.0) 4 (3.9) 33 (11.6) .07
Complex TGA 6 (5.0) 4 (3.9) 20 (7.0) .19
Ebstein 3 (2.5) 1 (0.98) 9 (3.2) .62
Unbalanced AVSD 6 (5.0) 1 (0.98) 14 (4.9) .19
Functional single ventricle
RV 36 (30) 50 (49) 157 (55) <.0001
LV 83 (70) 52 (51) 128 (45) <.0001
Palliative procedures performed before BCPA
Isolated MBTS 40 (33.6) 33 (32.3) 103 (36.1) .02
Norwood 30 (25.2) 50 (49.2) 118 (41.4) .05
PA band 16 (13.4) 12 (11.8) 45 (15.8) .99
Unifocalization 3 (2.5) 2 (2.0) 8 (2.8) .74
Ductal stent 1 (0.8) 2 (2.0) 2 (0.7) .30
HLHS, Hypoplastic left heart syndrome; TA, tricuspid atresia; PA, pulmonary atresia;
VSD, ventricular septal defect; IVS, intact ventricular septum; RV, right ventricle;
DILV, double-inlet left ventricle; L-TGA, levo-transposition of the great arteries;
PS, pulmonary stenosis; DORV, double-outlet right ventricle; TGA, transposition of
the great arteries; AVSD, atrioventricular septal defect; LV, left ventricle; BCPA,
bidirectional cavopulmonary anastomosis; MBTS, modified Blalock-Taussig shunt.
TABLE 2. Demographic and hemodynamic data at pre-BCPA and
pre-Fontan catheterization
Denver
(n ¼ 119)
Edmonton
(n ¼ 102)
Toronto
(n ¼ 285)
Pre-BCPA catheterization
No. of patients 104 80 259
Age (mo) 7.6  7.9 6.8  5.3 6.3  10.1
Weight (kg) 6.8  1.2 6.0  1.9 5.8  2.7
Body surface area (m2) 0.32  0.07 0.32  0.07 0.31  0.09
PAP (mm Hg)* 15.4  5.3 14.6  5.8 15.0  5.6
TPG (mm Hg)* 8.1  4.4 9.8  5.1 8.9  5.3
PVR (Wood units 3 m2)* 2.5  1.8 3.0  2.0 2.5  1.3
VEDP (mm Hg) 7.1  3.1 7.6  4.5 7.3  2.9
SaO2 (%)* 75.5  6.4 79.7  7.3 78.1  8.0
Pre-Fontan catheterization
No. of patients 49 59 170
Age (mo) 40.2  21.3 41.3  5.3 33.7  12.5
Weight (kg) 14.3  4.9 14.6  8.7 12.9  2.5
Body surface area (m2) 0.61  0.15 0.61  0.21 0.60  0.09
PAP (mm Hg)* 11.9  4.1 11.2  4.5 11.0  4.5
TPG (mm Hg) 5.2  2.1 6.4  2.9 5.7  1.7
PVR (Wood units 3 m2)* 1.9  1.6 2.5  1.4 1.9  1.0
VEDP (mm Hg) 8.8  5.3 6.7  3.8 7.4  3.0
SaO2 (%)* 81.5  5.8 83.6  5.7 85.6  8.3
Therewas no statistical significance in the correlations between the centers and any of
the values. BCPA, Bidirectional cavopulmonary anastomosis; PAP, pulmonary arte-
rial pressure; TPG, transpulmonary gradient; PVR, pulmonary vascular resistance;
VEDP, systemic ventricular end-diastolic pressure; Sao2, arterial oxygen saturation.
*Indicates P< .0001 in the decrease in PAP, TPG, and PVR and the increase in
SaO2 from pre-BCPA to pre-Fontan catheterization.
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Dcatheterization but did not have the Fontan operation; PVR
was less than 3 Wood units3m2 in all and none had BCPA
failure. In Toronto, among 28 patients who had pre-Fontan
catheterization but did not have the Fontan operation, PVR
was above 3Wood units3m2 in 3 patients (3.1, 4.8, and 6.5
Wood units 3 m2, respectively), the patient with PVR 6.5
Wood units 3 m2 died 15 months after BCPA; the other 2
patients did not have BCPA failure.FIGURE 1. The altitude distribution at the patient’s place of residence at
time of BCPA from the 3 centers.
The Journal of Thoracic and CarComparison of Pre-BCPA and Pre-Fontan
Hemodynamics and Postoperative Outcomes in the 3
Centers
Figure 2 shows the postoperative outcomes of the patients
in the 3 centers. Hemodynamic data at pre-BCPA and pre-
Fontan cardiac catheterization are shown in Table 2. There
was no significant relationship between centers and PAP,
PVR, TPG, VEDP, or arterial oxygen saturation. As shown
in Table 3, there was no significant relationship between
centers and cavopulmonary palliation failure after BCPA
and the Fontan operation. In addition, the survival at any
of the follow-up periods after BCPA did not significantly
relate to the centers.Relationship Between Altitude, Hemodynamics, and
Outcome
When data from the patients with pulmonary hemody-
namic data in the 3 centers were analyzed together, there
were no significant correlations between altitude and hemo-
dynamic variables at pre-BCPA and pre-Fontan catheteriza-
tion, nor palliation failure after BCPA or the Fontan
operation (Figure 3). BCPA failure correlated positively
with PVR (P ¼ .02) and the presence of a systemic right
ventricle (P ¼ .005). Fontan failure was correlated posi-
tively with PAP (P ¼ .04) and TPG (P ¼ .06) (Table 4).diovascular Surgery c Volume 146, Number 5 1167
FIGURE 2. Postoperative outcomes in the 3 centers. BCPA, Bidirectional cavopulmonary anastomosis; HTx, heart transplantation.
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DIn addition, PAP, PVR, and TPG decreased significantly
from pre-BCPA to pre-Fontan assessments (P<.0001 for
all) (Table 2). The decreases in the pulmonary hemody-
namic variables between the 2 stages of operations were
not correlated with altitude and other clinical variables
(P > .05 for all). VEDP did not change significantly
(P ¼ .31).DISCUSSION
Direct comparison of data among the 3 centers of varying
altitudes in Denver, Edmonton, and Toronto demonstrates
that low to moderate altitude did not significantly correlateTABLE 3. Comparison of the postoperative outcomes after BCPA and
Fontan operations including the period of surgical hospitalizations and
follow-up
Denver Edmonton Toronto
BCPA
No. of patients 119 102 285
Failure number 11 (9.2%) 3 (2.9%) 34 (11.9%)
Death 3 (2.5%) 1 (1.0%) 24 (8.4%)
Heart transplantation 8 (6.7%) 2 (2.0%) 10 (3.5%)
Fontan
No. of patients 49 69 155
Failure no. 3 (6.1%) 5 (7.2%) 11 (7.0%)
Death 0 (0%) 2 (2.9%) 9 (5.7%)
Heart transplantation 3 (6.1%) 3 (4.3%) 2 (1.3%)
Survival numbers after BCPA
1 y 115 (96.6%) 99 (97.1%) 260 (91.2%)
5 y 109 (91.6%) 95 (93.1%) 251 (88.1%)
10 y 106 (89.1%) 94 (92.2%) 249 (87.4%)
There was no statistical significance in the correlations between the centers and any of
the values. BCPA, Bidirectional cavopulmonary anastomosis.
1168 The Journal of Thoracic and Cardiovascular Surwith PAP, TPG, PVR, or VEDP at pre-BCPA or pre-Fontan
catheterization, or with the rate of BCPA or Fontan failure.
Risk factors for palliation failures included higher PVR,
PAP, TPG, and the presence of a systemic right ventricle
for all patients at varying altitudes.
Atmospheric pressure falls at a rate of 1% to 1.5% per
100 meters above sea level, which leads to reduction in the
partial pressure of oxygen (and the oxygen level in the atmo-
sphere is constantly 21% up to 110,000 meters).10 Thus, an
atmospheric pressure of 750, 690, and 640 mm Hg in Tor-
onto, Edmonton, and Denver leads to the partial pressure
of oxygen of 157, 145, and 134 mm Hg, respectively.
The first observation of hypoxic pulmonary vasoconstric-
tion was made in 1894 when Bradford and Dean described
increases in PAP in response to asphyxia.11 Half a century
later, it was realized as an adaptive phenomenon by von Eu-
ler and Liljestrand.12 In 1969, Marticorena and colleagues13
made the connection between sustained hypoxia and chronic
hypoxic pulmonary hypertension at high altitude in Peru
(4540 meters). The mechanism involves inhibition of
oxygen-sensitive Kþ channels and activation of voltage-
gated Ca2þ channels of pulmonary artery smooth muscle
cells, leading to Ca2þ influx and vasoconstriction, with sub-
sequentproliferationof smoothmuscle cells anda thickening
of the artery wall.14 Structural changes of pulmonary arteri-
oles by chronic hypoxia involve the small and muscular ‘‘re-
sistance’’ pulmonary arteries, resulting in elevated PVR and
right ventricular hypertrophy.15-18Most of these studies have
been conducted at high altitude above 3000 meters.
The conventional wisdom is that altitude, even low or
moderate, should elevate PAP and PVR, thus adversely af-
fect outcomes of cavopulmonary palliations in patientsgery c November 2013
FIGURE 3. Correlations between altitude and PVR in all the patients from the 3 centers at (A) pre-BCPA and (B) pre-Fontan catheterization. PVR, Pul-
monary vascular resistance; BCPA, bidirectional cavopulmonary anastomosis; HTx, heart transplantation.
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a few clinical reports. McMahon, Hicks, and Dreyer19 re-
ported a case of protein-losing enteropathy in a patient after
relocation from sea level to a higher altitude (1230 meters).
This resolved on moving back to a lower altitude. Darst and
associates20 reported reduced exercise tolerance in patients
residing in Denver compared with those in Toronto. Hos-
seinpour and associates6 reviewed published series from
24 centers with altitudes ranging up to 520meters and found
a correlation between altitude and early Fontan failure rate
defined as death, takedown of Fontan, or transplantation.
However, none of these studies assessed PAP or PVR.
In our study, pulmonary hemodynamic data were care-
fully collected from the pre-BCPA and pre-Fontan catheter-
ization assessments and analyzed in relation with
postoperative outcomes over a wide range of altitudes
from sea level to 2572 meters. Within this range, altitude
does not have a significant effect on PAP, TPG, PVR,
VEDP, nor on their decreases from pre-BCPA to pre-
Fontan catheterization assessments, nor on palliation fail-
ures. Our findings support previous single-center studiesTABLE 4. Relationships between pulmonary hemodynamics as
independent variables and palliation failure after BCPA and Fontan
operation as dependent variables
BCPA failure Fontan failure
Parameter estimate P value Parameter estimate P value
PVR 0.28 .02 0.27 .4
PAP 0.05 .2 0.10 .04
TPG 0.04 .28 0.08 .06
RV 1.04 .005 0.05 .6
BCPA, Bidirectional cavopulmonary anastomosis; PVR, pulmonary vascular resis-
tance; PAP, pulmonary arterial pressure; TPG, transpulmonary gradient; RV, right
ventricle as the systemic ventricle.
The Journal of Thoracic and Carshowing favorable outcomes at centers in Denver and Salt
Lake City that are comparable with those at sea level.7,8
Further, in concordance with previous studies, the risk
factors for palliation failures in patients at different
altitudes identified in our study are higher PAP, TPG,
PVR, and the presence of a systemic right ventricle.8,21
Several mechanisms may explain our findings. First,
Denver is considered to be at low to moderate altitude (by
altitude medicine standards), which leads to 20 to 30 mm
Hg reduction in partial pressure of oxygen or 3% to 4%
reduction of atmospheric oxygen level. Such reduction
may not cause significant structural changes in the pulmo-
nary vascular bed or changes in PAP or PVR, observed in
higher-altitude residents or during acute acclimatization
to moderate altitudes. Second, adaptive physiologic
changes may occur in residents exposed to chronic hypoxia
at elevated altitude, including increased systemic and pul-
monary production of nitric oxide, leading to a lower
PVR.3,22,23 This is different from acute acclimatization to
altitude, which is likely to have happened in the reported
post-Fontan patient in whom protein-losing enteropathy de-
veloped after relocation from sea level to a higher altitude.19
Palliative failures in patients with a functional single ventri-
cle are related to the anatomic variations of congenital heart
defects and consequent hemodynamic changes per se (such
as higher PAP, TPG, PVR, and the presence of a systemic
right ventricle8,21), but not altitude. As such, our study
reemphasizes the importance of cardiac catheterization
assessments of pulmonary hemodynamics before BCPA
and Fontan operations.
Limitations
This study is subject to several limitations owing to
its retrospective nature. First, inasmuch as only patientsdiovascular Surgery c Volume 146, Number 5 1169
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Dundergoing BCPAwere enrolled in the study, some patients
might have been precluded BCPA because of increased
PAP or/and PVR. However, such patients are few in prac-
tice and these data were unavailable. Second, clinical prac-
tice varied among the centers. In Denver, for instance,
patients with hypoplastic left heart syndrome tend to un-
dergo heart transplantation more frequently, accounting
for some of the difference in the distribution of cardiac di-
agnoses and surgical procedures before BCPA in the 3 cen-
ters. In addition, there were 2 patients in Denver who did
not undergo the Fontan operation because of high PVR
and were lost to follow-up. This may to some extent affect
the postoperative outcomes, but it should not affect the
main finding of our study, that is, the lack of relationship
between altitude and PVR. Third, in Edmonton, clinical
routine follow-up data collection was initiated much later
than in the other 2 centers, accounting for the longer
follow-up period. Therefore, the commonly used Kaplan-
Meier methodology was considered not best to reflect the
clinically ‘‘biased’’ situations among these 3 centers
when used to examine the difference in freedom from fail-
ures. Fourth, some data, such as the occurrence of protein-
losing enteropathy and detailed assessments of myocardial
function, were incomplete in some of the centers for com-
parison. Fifth, oxygen consumption was not directly mea-
sured, but calculated using predictive equations, which
tend to induce errors in oxygen consumption values (espe-
cially the LaFarge equation for children younger than 3
years old24,25). To reduce these errors, we used the
Lindulh equation to calculate oxygen consumption for all
the patients from the 3 centers.24 In addition, there might
be potential effect of altitude on oxygen consumption, but
this remains unknown.3 Finally, patients with functional
single ventricle undergoing staged palliations represent
the most complex group of patients in pediatric cardiology
and surgery, numerous factors such as congenital coexist-
ing anomalies in anatomy and physiology, atrioventricular
valve function, systemic ventricular function, and inter-
stage interventions may have an impact on pulmonary vas-
cularity and clinical outcomes. Our study focused on the
effect of altitude on pulmonary hemodynamics in relation
with postoperative outcomes. Further studies are warranted.
CONCLUSIONS
Low to moderate altitude does not have a significant im-
pact on pulmonary hemodynamics and postoperative out-
comes in patients with a functional single ventricle after
cavopulmonary palliations. Patients from the 3 centers in
Denver, Edmonton, and Toronto have similar outcomes af-
ter BCPA and the Fontan procedure. The risk factors for pal-
liation failure in all patients identified in our study included
higher PVR, PAP, TPG, and the presence of a systemic right
ventricle, but not altitude. These findings should help to
reorient clinical attention from the traditional focus on1170 The Journal of Thoracic and Cardiovascular Suraltitude to the anatomic variations of congenital heart de-
fects and consequent hemodynamic changes. Our study re-
emphasizes the importance of cardiac catheterization
assessments of pulmonary hemodynamics before BCPA
and Fontan operations.
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